Download the latest CRM Bulletin Issue 16, Available Now!

From the CEO’s Desk

At CRM, our vision is to establish Malaysia as a preferred destination for industry-sponsored research (ISR). We focus our work to meet the expectations of the clinical research industry as well as our investigators to provide the best for the people. As we approach the end of the year, 2018 has been the perfect embodiment of our efforts to reach that vision.

For the year 2018, we have seen that the number of studies for industry-sponsored research has been more than Bioavailability/Bioequivalence studies (BA/BE), at 79% and 21% respectively. Unlike previous years where BA/BE studies are always dominant, the trend is now changing, and we are seeing more industry-sponsored research being carried out here in Malaysia. Meaningful research provides intangible benefits to doctors and patients, especially in terms of treatment options. This change in trend is also reflective of the interest and traction the country is gaining from the clinical research industry worldwide. The industry is now beginning to see how Malaysia can be a fruitful investment for their clinical research efforts.

All of these would not be possible without the excellent work by our Principal Investigators (PI), Study Coordinators (SCs) and Clinical Research Centres (CRC). As an example, Dr. Toh Teck Hock and his clinical research team from Hospital Sibu in Sarawak were recognized as the world’s top 5 recruiter in the global RESPIRE RSV (Respiratory Syncytial Virus) study whereas Dr. Rohan Malek and his clinical research team at Hospital Selayang was the top recruiter for the ELIGANT study, which is a phase IV interventional study in prostate cancer patients in Asia. These international accomplishments are a testament to how far the clinical research landscape in Malaysia have grown and developed.

Finally, as a great ending to our arguably most productive year, I am proud to announce that CRM has successfully achieved the accreditation ISO 9001:2015 . CRM is the first clinical research organization in Malaysia to have achieved this accreditation and there is no one else more deserved to be credited with this achievement other than our people in CRM. They have worked tirelessly around the clock, providing training and getting trained, and keeping abreast with the stringent ISO requirements. We hope with this accreditation our stakeholders and industry players are now convinced that our services are of the highest standards. Here is to a more fruitful year ahead for everyone!

Dr. Akhmal Yusof
CEO, Clinical Research Malaysia